{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:03:24Z","timestamp":1789736604406,"version":"4.0.1"},"reference-count":100,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED Research Program","doi-asserted-by":"publisher","award":["JP23fk0410052"],"award-info":[{"award-number":["JP23fk0410052"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED Research Program","doi-asserted-by":"publisher","award":["JP23wm0325068"],"award-info":[{"award-number":["JP23wm0325068"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED Research Program","doi-asserted-by":"publisher","award":["JP21fk0108494"],"award-info":[{"award-number":["JP21fk0108494"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED Research Program","doi-asserted-by":"publisher","award":["JP22fk0108511"],"award-info":[{"award-number":["JP22fk0108511"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED Research Program","doi-asserted-by":"publisher","award":["JP22fk0108534"],"award-info":[{"award-number":["JP22fk0108534"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED Research Program","doi-asserted-by":"publisher","award":["JP22fk0410055"],"award-info":[{"award-number":["JP22fk0410055"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED Research Program","doi-asserted-by":"publisher","award":["22K07103"],"award-info":[{"award-number":["22K07103"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JSPS KAKENHI Grant-in-Aid for Scientific Research C","award":["JP23fk0410052"],"award-info":[{"award-number":["JP23fk0410052"]}]},{"name":"JSPS KAKENHI Grant-in-Aid for Scientific Research C","award":["JP23wm0325068"],"award-info":[{"award-number":["JP23wm0325068"]}]},{"name":"JSPS KAKENHI Grant-in-Aid for Scientific Research C","award":["JP21fk0108494"],"award-info":[{"award-number":["JP21fk0108494"]}]},{"name":"JSPS KAKENHI Grant-in-Aid for Scientific Research C","award":["JP22fk0108511"],"award-info":[{"award-number":["JP22fk0108511"]}]},{"name":"JSPS KAKENHI Grant-in-Aid for Scientific Research C","award":["JP22fk0108534"],"award-info":[{"award-number":["JP22fk0108534"]}]},{"name":"JSPS KAKENHI Grant-in-Aid for Scientific Research C","award":["JP22fk0410055"],"award-info":[{"award-number":["JP22fk0410055"]}]},{"name":"JSPS KAKENHI Grant-in-Aid for Scientific Research C","award":["22K07103"],"award-info":[{"award-number":["22K07103"]}]},{"name":"JSPS Leading Initiative for Excellent Young Researchers (LEADER)","award":["JP23fk0410052"],"award-info":[{"award-number":["JP23fk0410052"]}]},{"name":"JSPS Leading Initiative for Excellent Young Researchers (LEADER)","award":["JP23wm0325068"],"award-info":[{"award-number":["JP23wm0325068"]}]},{"name":"JSPS Leading Initiative for Excellent Young Researchers (LEADER)","award":["JP21fk0108494"],"award-info":[{"award-number":["JP21fk0108494"]}]},{"name":"JSPS Leading Initiative for Excellent Young Researchers (LEADER)","award":["JP22fk0108511"],"award-info":[{"award-number":["JP22fk0108511"]}]},{"name":"JSPS Leading Initiative for Excellent Young Researchers (LEADER)","award":["JP22fk0108534"],"award-info":[{"award-number":["JP22fk0108534"]}]},{"name":"JSPS Leading Initiative for Excellent Young Researchers (LEADER)","award":["JP22fk0410055"],"award-info":[{"award-number":["JP22fk0410055"]}]},{"name":"JSPS Leading Initiative for Excellent Young Researchers (LEADER)","award":["22K07103"],"award-info":[{"award-number":["22K07103"]}]},{"name":"Takeda Science Foundation","award":["JP23fk0410052"],"award-info":[{"award-number":["JP23fk0410052"]}]},{"name":"Takeda Science Foundation","award":["JP23wm0325068"],"award-info":[{"award-number":["JP23wm0325068"]}]},{"name":"Takeda Science Foundation","award":["JP21fk0108494"],"award-info":[{"award-number":["JP21fk0108494"]}]},{"name":"Takeda Science Foundation","award":["JP22fk0108511"],"award-info":[{"award-number":["JP22fk0108511"]}]},{"name":"Takeda Science Foundation","award":["JP22fk0108534"],"award-info":[{"award-number":["JP22fk0108534"]}]},{"name":"Takeda Science Foundation","award":["JP22fk0410055"],"award-info":[{"award-number":["JP22fk0410055"]}]},{"name":"Takeda Science Foundation","award":["22K07103"],"award-info":[{"award-number":["22K07103"]}]},{"name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","award":["JP23fk0410052"],"award-info":[{"award-number":["JP23fk0410052"]}]},{"name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","award":["JP23wm0325068"],"award-info":[{"award-number":["JP23wm0325068"]}]},{"name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","award":["JP21fk0108494"],"award-info":[{"award-number":["JP21fk0108494"]}]},{"name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","award":["JP22fk0108511"],"award-info":[{"award-number":["JP22fk0108511"]}]},{"name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","award":["JP22fk0108534"],"award-info":[{"award-number":["JP22fk0108534"]}]},{"name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","award":["JP22fk0410055"],"award-info":[{"award-number":["JP22fk0410055"]}]},{"name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","award":["22K07103"],"award-info":[{"award-number":["22K07103"]}]},{"name":"The Naito Foundation","award":["JP23fk0410052"],"award-info":[{"award-number":["JP23fk0410052"]}]},{"name":"The Naito Foundation","award":["JP23wm0325068"],"award-info":[{"award-number":["JP23wm0325068"]}]},{"name":"The Naito Foundation","award":["JP21fk0108494"],"award-info":[{"award-number":["JP21fk0108494"]}]},{"name":"The Naito Foundation","award":["JP22fk0108511"],"award-info":[{"award-number":["JP22fk0108511"]}]},{"name":"The Naito Foundation","award":["JP22fk0108534"],"award-info":[{"award-number":["JP22fk0108534"]}]},{"name":"The Naito Foundation","award":["JP22fk0410055"],"award-info":[{"award-number":["JP22fk0410055"]}]},{"name":"The Naito Foundation","award":["22K07103"],"award-info":[{"award-number":["22K07103"]}]},{"name":"Waksman Foundation of Japan","award":["JP23fk0410052"],"award-info":[{"award-number":["JP23fk0410052"]}]},{"name":"Waksman Foundation of Japan","award":["JP23wm0325068"],"award-info":[{"award-number":["JP23wm0325068"]}]},{"name":"Waksman Foundation of Japan","award":["JP21fk0108494"],"award-info":[{"award-number":["JP21fk0108494"]}]},{"name":"Waksman Foundation of Japan","award":["JP22fk0108511"],"award-info":[{"award-number":["JP22fk0108511"]}]},{"name":"Waksman Foundation of Japan","award":["JP22fk0108534"],"award-info":[{"award-number":["JP22fk0108534"]}]},{"name":"Waksman Foundation of Japan","award":["JP22fk0410055"],"award-info":[{"award-number":["JP22fk0410055"]}]},{"name":"Waksman Foundation of Japan","award":["22K07103"],"award-info":[{"award-number":["22K07103"]}]},{"name":"The Uehara Memorial Foundation","award":["JP23fk0410052"],"award-info":[{"award-number":["JP23fk0410052"]}]},{"name":"The Uehara Memorial Foundation","award":["JP23wm0325068"],"award-info":[{"award-number":["JP23wm0325068"]}]},{"name":"The Uehara Memorial Foundation","award":["JP21fk0108494"],"award-info":[{"award-number":["JP21fk0108494"]}]},{"name":"The Uehara Memorial Foundation","award":["JP22fk0108511"],"award-info":[{"award-number":["JP22fk0108511"]}]},{"name":"The Uehara Memorial Foundation","award":["JP22fk0108534"],"award-info":[{"award-number":["JP22fk0108534"]}]},{"name":"The Uehara Memorial Foundation","award":["JP22fk0410055"],"award-info":[{"award-number":["JP22fk0410055"]}]},{"name":"The Uehara Memorial Foundation","award":["22K07103"],"award-info":[{"award-number":["22K07103"]}]},{"name":"Kumamoto University COVID-19 Research Projects","award":["JP23fk0410052"],"award-info":[{"award-number":["JP23fk0410052"]}]},{"name":"Kumamoto University COVID-19 Research Projects","award":["JP23wm0325068"],"award-info":[{"award-number":["JP23wm0325068"]}]},{"name":"Kumamoto University COVID-19 Research Projects","award":["JP21fk0108494"],"award-info":[{"award-number":["JP21fk0108494"]}]},{"name":"Kumamoto University COVID-19 Research Projects","award":["JP22fk0108511"],"award-info":[{"award-number":["JP22fk0108511"]}]},{"name":"Kumamoto University COVID-19 Research Projects","award":["JP22fk0108534"],"award-info":[{"award-number":["JP22fk0108534"]}]},{"name":"Kumamoto University COVID-19 Research Projects","award":["JP22fk0410055"],"award-info":[{"award-number":["JP22fk0410055"]}]},{"name":"Kumamoto University COVID-19 Research Projects","award":["22K07103"],"award-info":[{"award-number":["22K07103"]}]},{"name":"International Joint Research Project of the Institute of Medical Science, the University of Tokyo","award":["JP23fk0410052"],"award-info":[{"award-number":["JP23fk0410052"]}]},{"name":"International Joint Research Project of the Institute of Medical Science, the University of Tokyo","award":["JP23wm0325068"],"award-info":[{"award-number":["JP23wm0325068"]}]},{"name":"International Joint Research Project of the Institute of Medical Science, the University of Tokyo","award":["JP21fk0108494"],"award-info":[{"award-number":["JP21fk0108494"]}]},{"name":"International Joint Research Project of the Institute of Medical Science, the University of Tokyo","award":["JP22fk0108511"],"award-info":[{"award-number":["JP22fk0108511"]}]},{"name":"International Joint Research Project of the Institute of Medical Science, the University of Tokyo","award":["JP22fk0108534"],"award-info":[{"award-number":["JP22fk0108534"]}]},{"name":"International Joint Research Project of the Institute of Medical Science, the University of Tokyo","award":["JP22fk0410055"],"award-info":[{"award-number":["JP22fk0410055"]}]},{"name":"International Joint Research Project of the Institute of Medical Science, the University of Tokyo","award":["22K07103"],"award-info":[{"award-number":["22K07103"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has acquired multiple mutations since its emergence. Analyses of the SARS-CoV-2 genomes from infected patients exhibit a bias toward C-to-U mutations, which are suggested to be caused by the apolipoprotein B mRNA editing enzyme polypeptide-like 3 (APOBEC3, A3) cytosine deaminase proteins. However, the role of A3 enzymes in SARS-CoV-2 replication remains unclear. To address this question, we investigated the effect of A3 family proteins on SARS-CoV-2 replication in the myeloid leukemia cell line THP-1 lacking A3A to A3G genes. The Wuhan, BA.1, and BA.5 variants had comparable viral replication in parent and A3A-to-A3G-null THP-1 cells stably expressing angiotensin-converting enzyme 2 (ACE2) protein. On the other hand, the replication and infectivity of these variants were abolished in A3A-to-A3G-null THP-1-ACE2 cells in a series of passage experiments over 20 days. In contrast to previous reports, we observed no evidence of A3-induced SARS-CoV-2 mutagenesis in the passage experiments. Furthermore, our analysis of a large number of publicly available SARS-CoV-2 genomes did not reveal conclusive evidence for A3-induced mutagenesis. Our studies suggest that A3 family proteins can positively contribute to SARS-CoV-2 replication; however, this effect is deaminase-independent.<\/jats:p>","DOI":"10.3390\/v16071141","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T15:05:51Z","timestamp":1721142351000},"page":"1141","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Potential Role of APOBEC3 Family Proteins in SARS-CoV-2 Replication"],"prefix":"10.3390","volume":"16","author":[{"given":"MST Monira","family":"Begum","sequence":"first","affiliation":[{"name":"Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5160-7724","authenticated-orcid":false,"given":"Ayub","family":"Bokani","sequence":"additional","affiliation":[{"name":"School of Engineering and Technology, CQ University, Sydney, NSW 2000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0743-1172","authenticated-orcid":false,"given":"Samiul Alam","family":"Rajib","sequence":"additional","affiliation":[{"name":"Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadeseh","family":"Soleimanpour","sequence":"additional","affiliation":[{"name":"Texas Biomedical Research Institute, San Antonio, TX 78227, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan"},{"name":"Department of Nursing, Kibi International University, Takahashi 716-8508, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Institute of Public Health, Tokyo 169-0073, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1495-7810","authenticated-orcid":false,"given":"Yorifumi","family":"Satou","sequence":"additional","affiliation":[{"name":"Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8577-0420","authenticated-orcid":false,"given":"Diako","family":"Ebrahimi","sequence":"additional","affiliation":[{"name":"Texas Biomedical Research Institute, San Antonio, TX 78227, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2869-9450","authenticated-orcid":false,"given":"Terumasa","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_3","unstructured":"WHO (2024, July 12). COVID-19 Public Health Emergency of International Concern (PHEIC) Global research and innovation forum. 12 February 2020. Available online: https:\/\/www.who.int\/publications\/m\/item\/covid-19-public-health-emergency-of-international-concern-(pheic)-global-research-and-innovation-forum."},{"key":"ref_4","unstructured":"WHO (2024, July 12). Statement on the Fifteenth Meeting of the IHR (2005) Emergency Committee on the COVID-19 Pandemic. 5 May 2023. Available online: https:\/\/www.who.int\/news\/item\/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jmb.2013.10.033","article-title":"Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all","volume":"426","author":"Desimmie","year":"2014","journal-title":"J. Mol. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.virol.2015.03.012","article-title":"APOBECs and virus restriction","volume":"479-480","author":"Harris","year":"2015","journal-title":"Virology"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ikeda, T., Yue, Y., Shimizu, R., and Nasser, H. (2021). Potential utilization of APOBEC3-mediated mutagenesis for an HIV-1 functional cure. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.686357"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Jonathan, M., and Ikeda, T. (2023). APOBEC3 family proteins as drivers of virus evolution. Front. Virol., 3.","DOI":"10.3389\/fviro.2023.1332010"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tibs.2007.01.004","article-title":"APOBEC-mediated viral restriction: Not simply editing?","volume":"32","author":"Holmes","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/wrna.1117","article-title":"Apolipoprotein B mRNA-editing, catalytic polypeptide cytidine deaminases and retroviral restriction","volume":"3","author":"Koito","year":"2012","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Cheng, A.Z., Moraes, S.N., Shaban, N.M., Fanunza, E., Bierle, C.J., Southern, P.J., Bresnahan, W.A., Rice, S.A., and Harris, R.S. (2021). APOBECs and herpesviruses. Viruses, 13.","DOI":"10.3390\/v13030390"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.3390\/v7062757","article-title":"APOBEC3 Interference during Replication of Viral Genomes","volume":"7","author":"Willems","year":"2015","journal-title":"Viruses"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cub.2004.12.068","article-title":"Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity","volume":"15","author":"Newman","year":"2005","journal-title":"Curr. Biol. CB"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1074\/jbc.M607298200","article-title":"APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G","volume":"282","author":"Holmes","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11220","DOI":"10.1128\/JVI.05238-11","article-title":"Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1","volume":"85","author":"Hultquist","year":"2011","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/JVI.02049-10","article-title":"Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity","volume":"85","author":"Wang","year":"2011","journal-title":"J. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Refsland, E.W., Hultquist, J.F., and Harris, R.S. (2012). Endogenous origins of HIV-1 G to A hypermutation and restriction in the nonpermissive T cell line CEM2n. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002800"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.chom.2013.09.006","article-title":"HIV-1 Vif adaptation to human APOBEC3H haplotypes","volume":"14","author":"Ooms","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Refsland, E.W., Hultquist, J.F., Luengas, E.M., Ikeda, T., Shaban, N.M., Law, E.K., Brown, W.L., Reilly, C., Emerman, M., and Harris, R.S. (2014). Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity. PLoS Genet., 10.","DOI":"10.1371\/journal.pgen.1004761"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41564-017-0063-9","article-title":"Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G","volume":"3","author":"Pollpeter","year":"2018","journal-title":"Nat. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ikeda, T., Shimizu, R., Nasser, H., Carpenter, M.A., Cheng, A.Z., Brown, W.L., Sauter, D., and Harris, R.S. (2023). APOBEC3 degradation is the primary function of HIV-1 Vif determining virion infectivity in the myeloid cell line THP-1. mBio, 14.","DOI":"10.1128\/mbio.00782-23"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13346","DOI":"10.1128\/JVI.01361-07","article-title":"Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1","volume":"81","author":"Miyagi","year":"2007","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","article-title":"DNA deamination mediates innate immunity to retroviral infection","volume":"113","author":"Harris","year":"2003","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1016\/j.jmb.2013.07.040","article-title":"The local dinucleotide preference of APOBEC3G can be altered from 5\u2019-CC to 5\u2019-TC by a single amino acid substitution","volume":"425","author":"Rathore","year":"2013","journal-title":"J. Mol. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Poulain, F., Lejeune, N., Willemart, K., and Gillet, N.A. (2020). Footprint of the host restriction factors APOBEC3 on the genome of human viruses. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008718"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1126\/science.1153201","article-title":"Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions","volume":"320","author":"Vartanian","year":"2008","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/JVI.00771-16","article-title":"Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses","volume":"90","author":"Verhalen","year":"2016","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"vev015","DOI":"10.1093\/ve\/vev015","article-title":"Role of the host restriction factor APOBEC3 on papillomavirus evolution","volume":"1","author":"Warren","year":"2015","journal-title":"Virus Evol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1038\/ncomms7881","article-title":"APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages","volume":"6","author":"Sharma","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"39100","DOI":"10.1038\/srep39100","article-title":"The double-domain cytidine deaminase APOBEC3G is a cellular site-specific RNA editing enzyme","volume":"6","author":"Sharma","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e4136","DOI":"10.7717\/peerj.4136","article-title":"Stem-loop structure preference for site-specific RNA editing by APOBEC3A and APOBEC3G","volume":"5","author":"Sharma","year":"2017","journal-title":"PeerJ"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/15476286.2016.1184387","article-title":"Transient overexpression of exogenous APOBEC3A causes C-to-U RNA editing of thousands of genes","volume":"14","author":"Sharma","year":"2017","journal-title":"RNA Biol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Sharma, S., Wang, J., Alqassim, E., Portwood, S., Cortes Gomez, E., Maguire, O., Basse, P.H., Wang, E.S., Segal, B.H., and Baysal, B.E. (2019). Mitochondrial hypoxic stress induces widespread RNA editing by APOBEC3G in natural killer cells. Genome Biol., 20.","DOI":"10.1186\/s13059-019-1651-1"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Alqassim, E.Y., Sharma, S., Khan, A., Emmons, T.R., Cortes Gomez, E., Alahmari, A., Singel, K.L., Mark, J., Davidson, B.A., and Robert McGray, A.J. (2021). RNA editing enzyme APOBEC3A promotes pro-inflammatory M1 macrophage polarization. Commun. Biol., 4.","DOI":"10.1038\/s42003-020-01620-x"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1038\/s41598-018-24448-2","article-title":"APOBEC3-mediated restriction of RNA virus replication","volume":"8","author":"Milewska","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1742-4690-6-38","article-title":"High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity","volume":"6","author":"Pauli","year":"2009","journal-title":"Retrovirology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1099\/vir.0.038919-0","article-title":"The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses","volume":"93","author":"Fehrholz","year":"2012","journal-title":"J. Gen. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1016\/j.ygeno.2020.09.028","article-title":"Mutations on COVID-19 diagnostic targets","volume":"112","author":"Wang","year":"2020","journal-title":"Genomics"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"10-1128","DOI":"10.1128\/mSphere.00408-20","article-title":"Rampant C\u2192U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories","volume":"5","author":"Simmonds","year":"2020","journal-title":"mSphere"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/nar\/gkac1238","article-title":"Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome","volume":"51","author":"Nakata","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"eabb5813","DOI":"10.1126\/sciadv.abb5813","article-title":"Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2","volume":"6","author":"Martignano","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"eabg0821","DOI":"10.1126\/science.abg0821","article-title":"SARS-CoV-2 within-host diversity and transmission","volume":"372","author":"Lythgoe","year":"2021","journal-title":"Science"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"17766","DOI":"10.1038\/s41598-020-74843-x","article-title":"Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses","volume":"10","author":"Kosuge","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"veab013","DOI":"10.1093\/ve\/veab013","article-title":"SARS-CoV-2 genomic analyses in cancer patients reveal elevated intrahost genetic diversity","volume":"7","author":"Siqueira","year":"2021","journal-title":"Virus Evol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"14972","DOI":"10.1038\/s41598-022-19067-x","article-title":"The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness","volume":"12","author":"Kim","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1099\/jgv.0.001276","article-title":"HIV-1 restriction by endogenous APOBEC3G in the myeloid cell line THP-1","volume":"100","author":"Ikeda","year":"2019","journal-title":"J. Gen. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.virol.2009.02.026","article-title":"Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent","volume":"387","author":"Browne","year":"2009","journal-title":"Virology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12977-018-0459-5","article-title":"Natural APOBEC3C variants can elicit differential HIV-1 restriction activity","volume":"15","author":"Anderson","year":"2018","journal-title":"Retrovirology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/JVI.02587-12","article-title":"Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4(+) T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination","volume":"87","author":"Gillick","year":"2013","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ikeda, T., Symeonides, M., Albin, J.S., Li, M., Thali, M., and Harris, R.S. (2018). HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007010"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Bishop, K.N., Verma, M., Kim, E.Y., Wolinsky, S.M., and Malim, M.H. (2008). APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.1000231"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.molcel.2017.12.010","article-title":"The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism","volume":"69","author":"Shaban","year":"2018","journal-title":"Mol. Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1093\/nar\/gkm750","article-title":"Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G","volume":"35","author":"Iwatani","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"32065","DOI":"10.1074\/jbc.M703423200","article-title":"APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription","volume":"282","author":"Li","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1093\/nar\/gkt527","article-title":"Binding of RNA by APOBEC3G controls deamination-independent restriction of retroviruses","volume":"41","author":"Belanger","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/JVI.02510-06","article-title":"Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G","volume":"81","author":"Nguyen","year":"2007","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Narvaiza, I., Linfesty, D.C., Greener, B.N., Hakata, Y., Pintel, D.J., Logue, E., Landau, N.R., and Weitzman, M.D. (2009). Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000439"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"10-1128","DOI":"10.1128\/JVI.00168-18","article-title":"Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor","volume":"92","author":"Stavrou","year":"2018","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1128\/JVI.00967-14","article-title":"Incorporation of mouse APOBEC3 into murine leukemia virus virions decreases the activity and fidelity of reverse transcriptase","volume":"88","author":"Boi","year":"2014","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/JVI.06594-11","article-title":"The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication","volume":"86","author":"Wang","year":"2012","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41467-023-36445-9","article-title":"APOBEC3B drives PKR-mediated translation shutdown and protects stress granules in response to viral infection","volume":"14","author":"Manjunath","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"15588","DOI":"10.1073\/pnas.0604524103","article-title":"High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition","volume":"103","author":"Chiu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"29105","DOI":"10.1074\/jbc.M601901200","article-title":"The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules","volume":"281","author":"Kozak","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1128\/JVI.02287-06","article-title":"Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules","volume":"81","author":"Kramer","year":"2007","journal-title":"J. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"9577","DOI":"10.1128\/JVI.02800-06","article-title":"Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association","volume":"81","author":"Niewiadomska","year":"2007","journal-title":"J. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Soros, V.B., Yonemoto, W., and Greene, W.C. (2007). Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H. PLoS Pathog., 3.","DOI":"10.1371\/journal.ppat.0030015"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1128\/JVI.00287-08","article-title":"Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins","volume":"82","author":"Holmes","year":"2008","journal-title":"J. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"7494","DOI":"10.1093\/nar\/gkx362","article-title":"Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation","volume":"45","author":"Xiao","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/nsmb.1497","article-title":"Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif","volume":"15","author":"Shirakawa","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.4049\/jimmunol.1302057","article-title":"GANP Interacts with APOBEC3G and Facilitates Its Encapsidation into the Virions To Reduce HIV-1 Infectivity","volume":"191","author":"Maeda","year":"2013","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"10-1128","DOI":"10.1128\/mBio.00737-20","article-title":"APOBEC3C Tandem Domain Proteins Create Super Restriction Factors against HIV-1","volume":"11","author":"McDonnell","year":"2020","journal-title":"mBio"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.2910260208","article-title":"Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)","volume":"26","author":"Tsuchiya","year":"1980","journal-title":"Int. J. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Berger, G., Durand, S., Fargier, G., Nguyen, X.N., Cordeil, S., Bouaziz, S., Muriaux, D., Darlix, J.L., and Cimarelli, A. (2011). APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002221"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.2002589117","article-title":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells","volume":"117","author":"Matsuyama","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"11881","DOI":"10.1021\/acsanm.1c02446","article-title":"Lethal Interactions of SARS-CoV-2 with Graphene Oxide: Implications for COVID-19 Treatment","volume":"4","author":"Fukuda","year":"2021","journal-title":"ACS Appl. Nano Mater."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Begum, M.M., Ichihara, K., Takahashi, O., Nasser, H., Jonathan, M., Tokunaga, K., Yoshida, I., Nagashima, M., Sadamasu, K., and Yoshimura, K. (2024). Virological characteristics correlating with SARS-CoV-2 spike protein fusogenicity. Front. Virol., 4.","DOI":"10.3389\/fviro.2024.1353661"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","article-title":"Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant","volume":"603","author":"Suzuki","year":"2022","journal-title":"Nature"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1016\/j.cell.2022.09.018","article-title":"Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5","volume":"185","author":"Kimura","year":"2022","journal-title":"Cell"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.chom.2022.10.003","article-title":"Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant","volume":"30","author":"Saito","year":"2022","journal-title":"Cell Host Microbe"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1039\/D3LF00250K","article-title":"SARS-CoV-2 inactivation: Assessing the efficacy of GO-anchored filters versus various commercial masks","volume":"1","author":"Islam","year":"2024","journal-title":"RSC Appl. Interfaces"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1039\/D3NA00084B","article-title":"SARS-CoV-2 suppression depending on the pH of graphene oxide nanosheets","volume":"5","author":"Islam","year":"2023","journal-title":"Nanoscale Adv."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1038\/s41467-023-38435-3","article-title":"Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants","volume":"14","author":"Tamura","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Tsujino, S., Deguchi, S., Nomai, T., Padilla-Blanco, M., Plianchaisuk, A., Wang, L., Begum, M.M., Uriu, K., Mizuma, K., and Nao, N. (2024). Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant. Microbiol. Immunol.","DOI":"10.1101\/2023.10.19.563209"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1038\/s41467-023-38188-z","article-title":"Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant","volume":"14","author":"Ito","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endopoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1093\/nar\/gkq174","article-title":"Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: Implications for HIV-1 restriction","volume":"38","author":"Refsland","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature11881","article-title":"APOBEC3B is an enzymatic source of mutation in breast cancer","volume":"494","author":"Burns","year":"2013","journal-title":"Nature"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.chom.2021.06.006","article-title":"SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity","volume":"29","author":"Motozono","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e01011-23","DOI":"10.1128\/jvi.01011-23","article-title":"Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics","volume":"97","author":"Kimura","year":"2023","journal-title":"J. Virol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s41467-024-45274-3","article-title":"Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant","volume":"15","author":"Tamura","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.chom.2024.01.001","article-title":"Virological characteristics of the SARS-CoV-2 BA.2.86 variant","volume":"32","author":"Tamura","year":"2024","journal-title":"Cell Host Microbe"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"105720","DOI":"10.1016\/j.isci.2022.105720","article-title":"The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant","volume":"25","author":"Kimura","year":"2022","journal-title":"iScience"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41586-021-04266-9","article-title":"Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation","volume":"602","author":"Saito","year":"2022","journal-title":"Nature"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jiac.2022.01.019","article-title":"A SARS-CoV-2 Delta variant containing mutation in the probe binding region used for RT-qPCR test in Japan exhibited atypical PCR amplification and might induce false negative result","volume":"28","author":"Rajib","year":"2022","journal-title":"J. Infect Chemother."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1093\/molbev\/msab118","article-title":"An Evolutionary Portrait of the Progenitor SARS-CoV-2 and Its Dominant Offshoots in COVID-19 Pandemic","volume":"38","author":"Kumar","year":"2021","journal-title":"Mol. Biol. Evol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.celrep.2012.12.008","article-title":"Deciphering signatures of mutational processes operative in human cancer","volume":"3","author":"Alexandrov","year":"2013","journal-title":"Cell Rep."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Lamb, K.D., Luka, M.M., Saathoff, M., Orton, R.J., Phan, M.V.T., Cotten, M., Yuan, K., and Robertson, D.L. (2024). Mutational signature dynamics indicate SARS-CoV-2\u2019s evolutionary capacity is driven by host antiviral molecules. PLoS Comput. Biol., 20.","DOI":"10.1371\/journal.pcbi.1011795"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/s41467-020-14730-1","article-title":"Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance","volume":"11","author":"Zhu","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/7\/1141\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:17:44Z","timestamp":1760109464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/7\/1141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":100,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["v16071141"],"URL":"https:\/\/doi.org\/10.3390\/v16071141","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]}}}